90556-87-9 Usage
General Description
3-Hydrazino-benzoic acid ethyl ester is a chemical compound with the molecular formula C9H11N3O2. It is an ethyl ester derivative of 3-hydrazino-benzoic acid and is commonly used in organic synthesis as a reagent for the preparation of various compounds. 3-HYDRAZINO-BENZOIC ACID ETHYL ESTER is a white to yellow crystalline powder with a melting point of 199-201 degrees Celsius. It is used in the synthesis of pharmaceutical compounds and in the production of dyes and pigments. 3-Hydrazino-benzoic acid ethyl ester is also utilized in the development of new materials and in scientific research as a versatile building block for the creation of diverse chemical structures.
Check Digit Verification of cas no
The CAS Registry Mumber 90556-87-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,5,5 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 90556-87:
(7*9)+(6*0)+(5*5)+(4*5)+(3*6)+(2*8)+(1*7)=149
149 % 10 = 9
So 90556-87-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O2/c1-2-13-9(12)7-4-3-5-8(6-7)11-10/h3-6,11H,2,10H2,1H3
90556-87-9Relevant articles and documents
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR
-
Paragraph 0259, (2015/12/19)
Disclosed are a 2-aminopyridine derivative having protein kinase inhibition activity, a preparation method and a pharmaceutical composition thereof Also disclosed are uses of the compounds and the pharmaceutical compositions thereof in the preparation of drugs for treating and/or preventing protein kinase-related diseases.
Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonists
Huang, Huang,Yu, Ying,Gao, Zhenting,Zhang, Yong,Li, Chenjing,Xu, Xing,Jin, Hui,Yan, Wenzhong,Ma, Ruoqun,Zhu, Jin,Shen, Xu,Jiang, Hualiang,Chen, Lili,Li, Jian
, p. 7037 - 7053 (2013/01/14)
LBVS of 12480 in-house compounds, followed by HTRF assay, resulted in one nonsteroidal compound (11) with antagonistic activity against FXR (69.01 ± 11.75 μM). On the basis of 11, 26 new derivatives (12a-z) were designed and synthesized accordingly. Five
